Company Search:
Advanced Search
Sponsored Links
Kaneh Bosm Biotechnology Inc Company Snapshot
Kaneh Bosm Biotechnology Inc operates in the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Kaneh Bosm Biotechnology Inc with three other pharmaceutical manufacturers in North America: RXi Pharmaceuticals Corp of the United States (2016 sales of $19,000.00 of which 100% was Pharmaceutical), Paratek Pharmaceuticals Inc of the United States ($29,000.00 of which 100% was Novel Therapeutics), and Sangui Biotech International, Incorporated which is also based in the United States ($48,009.00 ).

Sales Analysis.
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Kaneh Bosm Biotechnology Inc
  Stock Performance Chart for Kaneh Bosm Biotechnology Inc
  Stock Data: Recent Stock Performance:
  Current Price (3/16/2018): .40
(Figures in Canadian Dollars)
1 Week 33.3%   13 Weeks 42.9%  
4 Weeks 21.2%   52 Weeks 233.3%  
Kaneh Bosm Biotechnology Inc Key Data:
  Ticker: KBB Country: Canada
  Exchanges: Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2016 Sales 51,558
(Year Ending Jan 2017).
Employees: N/A
  Currency: Canadian Dollars Market Cap: 6,458,732
  Fiscal Yr Ends: February Shares Outstanding: 21,529,108
  Share Type: Closely Held Shares: 2,740,509
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.